Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
55.32
-1.32 (-2.32%)
Jul 23, 2026, 11:30 AM EDT - Market open
Forte Biosciences Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Forte Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $66.6. The average 1-year stock price forecast is 20.40% higher than the current stock price, while the lowest is $54 (-2.38%) and the highest is $75 (+35.59%).
Price Target: $66.6 (+20.40%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Forte Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $74 | Buy | Initiates | $74 | +33.78% | Jul 21, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $75 | Buy | Reiterates | $75 | +35.59% | Jul 10, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +10.28% | May 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $65 | Buy | Maintains | $65 | +17.51% | May 5, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.01
from -4.71
EPS Next Year
-4.14
from -4.01
EPS and Forward PE are based on non-GAAP adjusted numbers.